Who Is Eligible for a COVID-19 Booster?
Vaccine safety and efficacy : Oregon Health News Blog
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Bivalent mRNA booster effective, 'essential' for older adults
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Vaccines | Free Full-Text | Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
The bivalent vaccine booster outperforms - by Eric Topol
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
FDA advisory panel recommends Omicron-containing booster shots
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
Vaccines | Free Full-Text | Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Should I get a COVID-19 booster? | Science | AAAS
